Estimating the epidemiological impact and cost-effectiveness profile of a nonavalent HPV vaccine in Spain

Human papillomavirus (HPV) is one of the main causes of infection-related cancer. The bivalent vaccine (2vHPV) (16/18) and quadrivalent (6/11/16/18) HPV vaccine (4vHPV) have been included in the Spanish vaccination calendar since 2007. The new nonavalent HPV vaccine (9vHPV), approved in Europe in 20...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jesús De La Fuente (Author), Juan José Hernandez Aguado (Author), María San Martín (Author), Paula Ramirez Boix (Author), Sergio Cedillo Gómez (Author), Noelia López (Author)
Format:	Book
Published:	Taylor & Francis Group, 2019-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cost-effectiveness of nonavalent HPV vaccination in the Netherlands
by: Cody Palmer, et al.
Published: (2024)

Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccine
by: Karl-Ulrich Petry, et al.
Published: (2018)

9vHPV (Nonavalent) Vaccine Policy in Indonesia
by: Yudi M. Hidayat, et al.
Published: (2023)

Cost-effectiveness and epidemiological impact of gender-neutral HPV vaccination in Spain
by: Renata Linertová, et al.
Published: (2022)

Concurrent nonavalent human papillomavirus (HPV) vaccination and immune stimulation with imiquimod to treat recalcitrant HPV-associated high grade vaginal intra-epithelial neoplasia
by: R. Farrell, et al.
Published: (2024)

Potential impact of a nonavalent HPV vaccine on HPV related low-and high-grade cervical intraepithelial lesions: A referral hospital-based study in Sicily
by: Giuseppina Capra, et al.
Published: (2017)

Nonavalent human papillomavirus vaccination as a treatment for warts in an immunosuppressed adult
by: Sara B. Ferguson, MD, et al.
Published: (2017)

Childhood erythrodermic lichen planus pemphigoides after nonavalent human papillomavirus vaccination
by: Laura Pizzatti, MD, et al.
Published: (2020)

Antibody persistence after a single dose of quadrivalent HPV vaccine and the effect of a dose of nonavalent vaccine given 3-8 years later - an exploratory study
by: Vladimir Gilca, et al.
Published: (2019)

Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis
by: Kate T Simms, DrPhD, et al.
Published: (2016)

Updated medical care cost estimates for HPV-associated cancers: implications for cost-effectiveness analyses of HPV vaccination in the United States
by: Harrell W. Chesson, et al.
Published: (2019)

Estimated cost-effectiveness and burden of disease associated with quadrivalent cell-based and egg-based influenza vaccines in Spain
by: Jesús Ruiz-Aragón, et al.
Published: (2020)

Nonavalent Human Papillomavirus Vaccination as a Treatment for Skin Warts in Immunosuppressed Adults: A Case Series
by: Simon Bossart, et al.
Published: (2020)

Comparative cost analysis of cervical cancer screening programme based on molecular detection of HPV in Spain
by: R. Ibáñez, et al.
Published: (2021)

[Translated article] Epidemiology of Melanoma in Spain: Estimation of Number of Patients With Stage III Disease Eligible for Adjuvant Therapies
by: E. Nagore, et al.
Published: (2022)

Hepatitis C hospitalizations in Spain, 2004-2013: a retrospective epidemiological study
by: R. Boix, et al.
Published: (2017)

Cost-effectiveness of Human Papilloma Virus (HPV) vaccination in Nigeria: a decision analysis using pragmatic parameter estimates for cost and programme coverage
by: Obinna I. Ekwunife, et al.
Published: (2017)

HPV vaccination coverage: slightly improved two‐dose schedule completion estimates and historical estimates lower on AIR than HPV Register
by: Julia Brotherton, et al.
Published: (2022)

Cancer cost profiles: The Epicost estimation approach
by: Silvia Francisci, et al.
Published: (2022)

Epidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCC-Spain study
by: Inés Gómez-Acebo, et al.
Published: (2018)

Description of preterm neonates admitted and readmitted in Spain: causes and cost
by: Juliana de Jesus Alves, et al.
Published: (2019)

Epidemiological trends of sepsis in the twenty-first century (2000-2013): an analysis of incidence, mortality, and associated costs in Spain
by: Alejandro Álvaro-Meca, et al.
Published: (2018)

Rural School in Spain: Between Compensatory Education and Inclusive Education
by: Roser Boix-Tomàs, et al.
Published: (2015)

Changing Trends in the Epidemiology and Risk Factors of Pneumocystis Pneumonia in Spain
by: Estefanía Pereira-Díaz, et al.
Published: (2019)

Analysis of the Economic and Socio-Demographic Burden of HPV-Associated Diseases and the Cost-Effectiveness of HPV Vaccination in Russia
by: Alexander A. Baranov, et al.
Published: (2019)

Modeling the epidemiological impact and cost-effectiveness of a combined schoolgirl HPV vaccination and cervical cancer screening program among Chinese women
by: Xiaomeng Ma, et al.
Published: (2021)

Neonatal Infection Due to SARS-CoV-2: An Epidemiological Study in Spain
by: Belén Fernández Colomer, et al.
Published: (2020)

The effect of making a 'third dose assumption' on HPV coverage estimates
by: Julia M. Brotherton, et al.
Published: (2015)

Estimating the time required to reach HPV vaccination targets across Europe
by: Ilias Gountas, et al.
Published: (2024)

Epidemiology of Leprosy in Spain: The Role of the International Migration.
by: José M Ramos, et al.
Published: (2016)

Cost-effectiveness analysis of chronic hepatitis C treatment in the prison population in Spain
by: A Marco, et al.
Published: (2020)

Estimating non-communicable disease treatment costs using probability-based cost estimation
by: Claire R. Botha, et al.
Published: (2022)

Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain
by: Mareque M, et al.
Published: (2021)

Recommendations on the skills profile and standards of the neonatal transport system in Spain
by: Raquel Jordán Lucas, et al.
Published: (2021)

Economic burden of Cardiac Arrest in Spain: analyzing healthcare costs drivers and treatment strategies cost-effectiveness
by: Mariano Matilla-García, et al.
Published: (2023)

Implementation strategy and cost of Mozambique's HPV vaccine demonstration project
by: Caroline Soi, et al.
Published: (2019)

An Estimation of the Incidence of Thyroiditis Among Girls in Primary Care in Spain
by: Elisa Martín-Merino, et al.
Published: (2021)

Estimating the COVID-19 Prevalence in Spain With Indirect Reporting via Open Surveys
by: Augusto Garcia-Agundez, et al.
Published: (2021)

Gripe y vacunación: dos caras de la misma moneda
by: Javier de la Fuente Aguado
Published: (2018)

Enterococco y sonda urinaria: un binomio peligroso
by: Javier de la Fuente Aguado
Published: (2022)